TickerFacts.

Akebia Therapeutics, Inc. (AKBA): Total Assets

Annual figures by period end, from SEC filings.

$376.56M
As of 2025-12-31
$349.66M
As of 2026-06-30
+1.9%
3-year compound annual growth
-10.2%
5-year compound annual growth
+10.2%
10-year compound annual growth
$996.54M2013-12-31: $34.66M2014-12-31: $111.00M2015-12-31: $142.94M2016-12-31: $300.22M2017-12-31: $364.25M2018-12-31: $996.54M2019-12-31: $771.20M2020-12-31: $644.14M2021-12-31: $529.35M2022-03-31: $541.80M2022-06-30: $529.88M2022-09-30: $444.25M2022-12-31: $356.05M2023-12-31: $241.70M2024-12-31: $220.67M2025-12-31: $376.56M$376.56M
2013-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$376.56M+70.6%2026-02-26, Balance as of period end
2024-12-31$220.67M-8.7%2026-02-26, Balance as of period end
2023-12-31$241.70M-32.1%2025-03-13, Balance as of period end
2022-12-31$356.05Mn/a2024-03-14, Balance as of period end
2022-09-30$444.25Mn/a2023-08-28, Balance as of period end
2022-06-30$529.88Mn/a2023-08-28, Balance as of period end
2022-03-31$541.80Mn/a2023-08-28, Balance as of period end
2021-12-31$529.35M-17.8%2023-08-28, Balance as of period end
2020-12-31$644.14M-16.5%2022-03-01, Balance as of period end
2019-12-31$771.20M-22.6%2021-02-25, Balance as of period end
2018-12-31$996.54M+173.6%2020-03-12, Balance as of period end
2017-12-31$364.25M+21.3%2019-03-26, Balance as of period end
2016-12-31$300.22M+110.0%2018-03-12, Balance as of period end
2015-12-31$142.94M+28.8%2017-03-06, Balance as of period end
2014-12-31$111.00M+220.2%2016-03-14, Balance as of period end
2013-12-31$34.66Mn/a2015-03-04, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Akebia Therapeutics, Inc. (AKBA)2025-12-31$376.56M+70.6%
Anaptysbio, Inc (ANAB)2025-12-31$364.39M-24.7%
Keros Therapeutics, Inc. (KROS)2025-12-31$338.02M-45.1%
Puma Biotechnology, Inc. (PBYI)2025-12-31$216.30M+1.4%
Arcus Biosciences, Inc. (RCUS)2025-12-31$1.14B-1.0%
IDEAYA Biosciences, Inc. (IDYA)2025-12-31$1.11B-1.3%
Schrodinger, Inc. (SDGR)2025-12-31$726.16M-11.8%
Vanda Pharmaceuticals Inc. (VNDA)2025-12-31$488.95M-25.5%
Amarin Corp PLC (AMRN)2025-12-31$670.77M-2.1%

Compare AKBA, ANAB, KROS, PBYI side by side · Screen every company in Pharmaceutical Preparations ↗